FDA urged to publish follow-up studies on covid-19 vaccine safety signals
BMJ
.
2022 Oct 25:379:o2527.
doi: 10.1136/bmj.o2527.
Author
Maryanne Demasi
1
Affiliation
1
Sydney, Australia.
PMID:
36283706
DOI:
10.1136/bmj.o2527
No abstract available
MeSH terms
COVID-19 Vaccines* / adverse effects
COVID-19* / prevention & control
Follow-Up Studies
Humans
Substances
COVID-19 Vaccines